These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7045328)

  • 1. [Inhibitory effect of 2-(4-(2-imidazo(1,2-a)pyridyl)phenyl) propionic acid (miroprofen) on platelet aggregation and prostaglandin I2 generation (author's transl)].
    Mikashima H; Goto K
    Yakugaku Zasshi; 1982 Jan; 102(1):99-103. PubMed ID: 7045328
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitory effect of TN-762 (suprofen) on platelet aggregation].
    Imai H; Muramatsu Y; Niu K; Nozaki M; Fujimura H
    Nihon Yakurigaku Zasshi; 1982 Jul; 80(1):61-8. PubMed ID: 6757067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory activity of an imidazopyridine derivative (miroprofen).
    Maruyama Y; Anami K; Terasawa M; Goto K; Imayoshi T; Kadobe Y; Mizushima Y
    Arzneimittelforschung; 1981; 31(7):1111-8. PubMed ID: 7196760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacology of prostacyclin].
    Imai S
    Kokyu To Junkan; 1985 Jul; 33(7):845-9. PubMed ID: 2997894
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of aspirin on prostacyclin production (author's transl)].
    Maekawa T; Kobayashi N; Tanaka S; Arai H
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):551-2. PubMed ID: 386695
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostaglandin I2 (prostacyclin).
    Kelton JG; Blajchman MA
    Can Med Assoc J; 1980 Jan; 122(2):175-9. PubMed ID: 6988063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostaglandin I2 (PG I2; prostacyclin) synthesis by human gastric mucosa (author's transl)].
    Sinzinger H; Silberbauer K; Seyfried H; Winter M
    Wien Klin Wochenschr; 1979 Nov; 91(22):768-71. PubMed ID: 390892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental assessment of some pharmacodynamic features of ketoprofen lysine. Pain relief activity, antipyretic effects, anti-inflammatory activity, anti-platelet aggregation activity and interference with the biosynthesis of prostaglandins].
    Marmo E; Ottavo R; Giordano L; Paone G; Falcone O; Spaziante G; Visone C; Campidonico U
    Arch Sci Med (Torino); 1980; 137(3):387-404. PubMed ID: 6786255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulcerogenicity and effect on inhibition of prostaglandin generation of indometacin farnesil, a prodrug of indomethacin, in rat gastric mucosa: comparison with indomethacin or loxoprofen.
    Arakawa T; Fukuda T; Nakagawa K; Higuchi K; Watanabe T; Tominaga K; Kobayashi K
    Drugs Exp Clin Res; 1995; 21(3):85-8. PubMed ID: 7555616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral aspirin dose on platelet aggregation and arterial prostacyclin synthesis: studies in humans and rabbits.
    Ellis EF; Jones PS; Wright KF; Richardson DW; Ellis CK
    Adv Prostaglandin Thromboxane Res; 1980; 6():313-5. PubMed ID: 6770601
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of an inhibitor of platelet aggregation [prostacycline] derived from rat arterial wall (author's transl)].
    García-Conde J; Merino J; Benet I
    Sangre (Barc); 1978; 23(5):526-34. PubMed ID: 368997
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential inhibition of prostacyclin production and platelet aggregation by aspirin.
    Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
    Lancet; 1979 Dec; 2(8154):1213-7. PubMed ID: 92623
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro inhibition by endotoxin of the anti-aggregatory action of prostacyclin produced by aortic rings.
    Bult H; Herman AG
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):335-6. PubMed ID: 361006
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of prostaglandin synthesis by indoprofen.
    Stygles VG; Newton JF; Hook JB
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):329-40. PubMed ID: 411162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrocortisone inhibits platelet prostaglandin and endothelial prostacyclin production.
    Jørgensen KA; Stoffersen E
    Pharmacol Res Commun; 1981 Jun; 13(6):579-86. PubMed ID: 6794043
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and inhibitory effects of 2-pyridyl-2-thiobenzoxazole and 2-pyridyl-2-thiobenzimidazole derivatives on arachidonic acid metabolism.
    Lagorce JF; Fatimi J; Lakhdar M; Chabernaud ML; Buxeraud J; Raby C
    Arzneimittelforschung; 1995 Nov; 45(11):1207-10. PubMed ID: 8929241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of the venous wall--platelet interaction by dihydroergotamine (author's transl)].
    Silberbauer K; Fitscha P; Sinzinger H
    Wien Klin Wochenschr; 1981 Oct; 93(18):577-9. PubMed ID: 7029927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacodynamic properties of fluproquazone.
    Hill RC; Foote RW; Roemer D
    Arzneimittelforschung; 1981; 31(5a):873-82. PubMed ID: 6973980
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostacyclin and the vascular endothelium.
    Moncada S; Vane JR
    Bull Eur Physiopathol Respir; 1981; 17(4):687-701. PubMed ID: 7034824
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of changes in dietary prostaglandin precursor fatty acids on arterial blood pressure and vascular prostacyclin synthesis.
    Düsing R; Scherhag R; Glänzer K; Budde U; Kramer HJ
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():209-15. PubMed ID: 6221595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.